O3.06 * the Effect of Acetyl-L-Carnitine in Reducing the Taxanes Induced Neuropathy

Acetyl-L-carnitine undervalued in the treatment of chemotherapy-induced peripheral neuropathy?

“…Furthermore, one study showed that ALC had no significant effect on neuropathy among patients treated for multiple myeloma with bortezomib-doxorubicin-dexamethasone [16]. In contrast, the available abstracts generally conclude a therapeutic and preventive effect of ALC on CIPN [17][18][19]. Two studies reported no interference of ALC with anti-tumor activity of the chemotherapeutics used [13,17].…”